Literature DB >> 21886742

A huge infiltrating squamous cell carcinoma of the neck 46 years after radiotherapy of a haemangioma.

Konstanze Scheller1, Alexander Walter Eckert, Christian Scheller.   

Abstract

BACKGROUND: There is a higher risk for malignant tumours in patients who underwent any kind of radiotherapy. MAIN OBSERVATIONS: An 87-year-old patient with an extended squamous cell carcinoma of the neck was referred to our hospital. The large ulcerated tumour showed a deep infiltration of the para-vertebral muscles and the spinal processes C6-C7. The tumour was known since about six years and appeared about 46 years after low-dose radiotherapy of a cervical haemangioma of the neck in 1961. The large dimension of the tumour leaded to a radical surgical removal and a sufficient fast reconstruction strategy. The extended defect was covered by a pedicled lower musculocutaneous trapezius flap. No postoperative complications like partial necrosis, infection or movement disorders of the shoulder or a shoulder drop syndrome were seen. Ten weeks after the operation the patient showed a good functional and aesthetic result with no limitation of arm mobility. Two and a half years after radical intended surgery the patient was still alive and showed no recurrence of the tumour.
CONCLUSIONS: In conclusion there is a need for a life-time lasting dermatological supervision in patients with a history of radiotherapy in the past, because the handling of patients with such an enlarged tumour is complicated.

Entities:  

Keywords:  haemangioma; radiotherapy; squamous cell carcinoma; trapezius flap

Year:  2010        PMID: 21886742      PMCID: PMC3157812          DOI: 10.3315/jdcr.2010.1046

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  10 in total

1.  Radiotherapy of childhood haemangiomas: from active treatment to radiation risk estimates.

Authors:  S Lindberg
Journal:  Radiat Environ Biophys       Date:  2001-09       Impact factor: 1.925

Review 2.  Nonmelanoma cancers of the skin.

Authors:  D S Preston; R S Stern
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

3.  Infiltrating basal cell carcinoma of the neck 34 years after irradiation of an haemangioma in early childhood. A case-report.

Authors:  Georg Eggers; Christa Flechtenmacher; Hjalmar Kurzen; Stefan Hassfeld
Journal:  J Craniomaxillofac Surg       Date:  2005-04-26       Impact factor: 2.078

4.  Anatomic basis of the lower trapezius musculocutaneous flap.

Authors:  A H Weiglein; F Haas; G Pierer
Journal:  Surg Radiol Anat       Date:  1996       Impact factor: 1.246

5.  Skin cancer in patients with chronic radiation dermatitis.

Authors:  M M Davis; C W Hanke; T W Zollinger; J F Montebello; N B Hornback; A L Norins
Journal:  J Am Acad Dermatol       Date:  1989-04       Impact factor: 11.527

6.  The pectoralis major myocutaneous flap. A versatile flap for reconstruction in the head and neck.

Authors:  S Ariyan
Journal:  Plast Reconstr Surg       Date:  1979-01       Impact factor: 4.730

7.  Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.

Authors:  M R Karagas; J A McDonald; E R Greenberg; T A Stukel; J E Weiss; J A Baron; M M Stevens
Journal:  J Natl Cancer Inst       Date:  1996-12-18       Impact factor: 13.506

Review 8.  Cancer risks from medical radiation.

Authors:  Elaine Ron
Journal:  Health Phys       Date:  2003-07       Impact factor: 1.316

9.  Cancer incidence after radiotherapy for skin haemangioma during infancy.

Authors:  S Lindberg; P Karlsson; B Arvidsson; E Holmberg; L M Lunberg; A Wallgren
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

10.  Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential modification of risk by sun exposure.

Authors:  Margaret R Karagas; Heather H Nelson; Michael S Zens; Martha Linet; Therese A Stukel; Steve Spencer; Katie M Applebaum; Leila Mott; Kiyohiko Mabuchi
Journal:  Epidemiology       Date:  2007-11       Impact factor: 4.822

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.